RAD50 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.574600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.007600E-01
Normal-vs-Stage2
9.425200E-01
Normal-vs-Stage3
3.021900E-02
Normal-vs-Stage4
5.859200E-01
Stage1-vs-Stage2
4.782400E-01
Stage1-vs-Stage3
1.496680E-03
Stage1-vs-Stage4
7.425600E-01
Stage2-vs-Stage3
2.220200E-02
Stage2-vs-Stage4
5.547400E-01
Stage3-vs-Stage4
1.688370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.753400E-01
Normal-vs-AfricanAmerican
9.284800E-01
Normal-vs-Asian
9.594200E-01
Caucasian-vs-AfricanAmerican
9.269800E-01
Caucasian-vs-Asian
8.908200E-01
AfricanAmerican-vs-Asian
8.823400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.826600E-01
Normal-vs-Female
9.345000E-01
Male-vs-Female
8.090800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.553400E-01
Normal-vs-Age(41-60Yrs)
6.507800E-01
Normal-vs-Age(61-80Yrs)
8.472800E-01
Normal-vs-Age(81-100Yrs)
9.651800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.909000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.573200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.961600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.767790E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.582600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.880200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.200800E-01
Normal-vs-Daily Drinker
7.108000E-01
Normal-vs-Weekly Drinker
7.443800E-01
Normal-vs-Occasional Drinker
8.287600E-01
Normal-vs-Social Drinker
3.207200E-01
Non Drinker-vs-Daily Drinker
5.920800E-01
Non Drinker-vs-Weekly Drinker
6.868400E-01
Non Drinker-vs-Occasional Drinker
5.390600E-01
Non Drinker-vs-Social Drinker
9.285600E-02
Daily Drinker-vs-Weekly Drinker
9.552000E-01
Daily Drinker-vs-Occasional Drinker
2.694600E-01
Daily Drinker-vs-Social Drinker
2.829600E-02
Weekly Drinker-vs-Occasional Drinker
3.548600E-01
Weekly Drinker-vs-Social Drinker
5.034100E-02
Occasional Drinker-vs-Social Drinker
2.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.672500E-02
Normal-vs-Grade 2
7.680300E-03
Normal-vs-Grade 3
4.280700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.412960E-01
Grade 1-vs-Grade 3
7.396100E-03
Grade 1-vs-Grade 4
3.672500E-02
Grade 2-vs-Grade 3
4.842300E-02
Grade 2-vs-Grade 4
7.680300E-03
Grade 3-vs-Grade 4
4.280700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.167000E-01
Normal-vs-NonDiabetic
9.702600E-01
Diabetic-vs-NonDiabetic
5.528200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.475200E-01
Normal-vs-NoPancreatitis
9.468000E-01
Pancreatitis-vs-NoPancreatitis
6.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.147400E-01
Normal-vs-N1
9.684600E-01
N0-vs-N1
7.735000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.717000E-01
Normal-vs-TP53-NonMutant
7.282200E-01
TP53-Mutant-vs-TP53-NonMutant
3.614000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
